多普勒超声腔内心电一体化引导建立和维护中心血管通路专家共识

2020-04-10 中国介入放射学相关专家组(统称) 中国介入影像与治疗学.2020.17(4):193-197.

中心血管通路装置是治疗临床重症、肿瘤、长期需要进行静脉输液患者的重要工具。选择适当的穿刺部位和血管,确保正确的导管头端位置,对维护其长期通畅率,降低感染、血栓形成、导管异位等并发症的发生率至关重要。应

中文标题:

多普勒超声腔内心电一体化引导建立和维护中心血管通路专家共识

发布日期:

2020-04-10

简要介绍:

中心血管通路装置是治疗临床重症、肿瘤、长期需要进行静脉输液患者的重要工具。选择适当的穿刺部位和血管,确保正确的导管头端位置,对维护其长期通畅率,降低感染、血栓形成、导管异位等并发症的发生率至关重要。应用多普勒超声行血管评估与穿刺,结合腔内心电定位导管头端位置,替代传统盲目穿刺及置管术后X线定位,可避免孕妇、新生儿及儿童等患者射线暴露损伤。将多普勒超声与腔内心电定位技术有机结合的一体化设备称为多普勒超声腔内心电一体化引导(EDUG),现已广泛应用于临床,成为辅助临床微创手术、介入治疗、急诊抢救和临床护理操作的新方法。中国医学装备协会心血管装备技术专业委员会联合中国介入医学产业技术创新联盟经皮血管通路创新中心、中国医师协会介入医师分会介入医学工程与生物技术专业委员会有关专家,结合临床实践形成专家共识,为医护人员提供参考。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=【医脉通】多普勒超声腔内心电一体化引导建立和维护中心血管通路专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=132f91c00189a017, title=多普勒超声腔内心电一体化引导建立和维护中心血管通路专家共识, enTitle=, guiderFrom=中国介入影像与治疗学.2020.17(4):193-197., authorId=0, author=, summary=中心血管通路装置是治疗临床重症、肿瘤、长期需要进行静脉输液患者的重要工具。选择适当的穿刺部位和血管,确保正确的导管头端位置,对维护其长期通畅率,降低感染、血栓形成、导管异位等并发症的发生率至关重要。应, cover=https://img.medsci.cn/2020422/1587555506537_2020535.jpg, journalId=0, articlesId=null, associationId=1274, associationName=中国介入放射学相关专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Fri Apr 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>中心血管通路装置是治疗临床重症、肿瘤、长期需要进行静脉输液患者的重要工具。选择适当的穿刺部位和血管,确保正确的导管头端位置,对维护其长期通畅率,降低感染、血栓形成、导管异位等并发症的发生率至关重要。应用多普勒超声行血管评估与穿刺,结合腔内心电定位导管头端位置,替代传统盲目穿刺及置管术后X线定位,可避免孕妇、新生儿及儿童等患者射线暴露损伤。将多普勒超声与腔内心电定位技术有机结合的一体化设备称为多普勒超声腔内心电一体化引导(EDUG),现已广泛应用于临床,成为辅助临床微创手术、介入治疗、急诊抢救和临床护理操作的新方法。中国医学装备协会心血管装备技术专业委员会联合中国介入医学产业技术创新联盟经皮血管通路创新中心、中国医师协会介入医师分会介入医学工程与生物技术专业委员会有关专家,结合临床实践形成专家共识,为医护人员提供参考。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=55745, tagName=多普勒超声), TagDto(tagId=102817, tagName=中心血管)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=55745, guiderKeyword=多普勒超声, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2007, appHits=63, showAppHits=40, pcHits=568, showPcHits=1949, likes=0, shares=4, comments=10, approvalStatus=1, publishedTime=Wed Apr 22 20:14:38 CST 2020, publishedTimeString=2020-04-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Apr 22 19:38:40 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 20:41:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=【医脉通】多普勒超声腔内心电一体化引导建立和维护中心血管通路专家共识.pdf)])
【医脉通】多普勒超声腔内心电一体化引导建立和维护中心血管通路专家共识.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1078260, encodeId=aa5b10e826028, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:37:48 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063093, encodeId=48ca1063093f2, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:55:10 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063091, encodeId=96a41063091d5, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:47:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056680, encodeId=ad5d1056680e7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Oct 01 00:04:27 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964176, encodeId=66ee9641e695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:42:51 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-12-09 一己怀

    收藏了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1078260, encodeId=aa5b10e826028, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:37:48 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063093, encodeId=48ca1063093f2, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:55:10 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063091, encodeId=96a41063091d5, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:47:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056680, encodeId=ad5d1056680e7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Oct 01 00:04:27 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964176, encodeId=66ee9641e695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:42:51 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-10-23 ms1000000819631724

    收藏了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1078260, encodeId=aa5b10e826028, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:37:48 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063093, encodeId=48ca1063093f2, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:55:10 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063091, encodeId=96a41063091d5, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:47:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056680, encodeId=ad5d1056680e7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Oct 01 00:04:27 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964176, encodeId=66ee9641e695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:42:51 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-10-23 ms1000000819631724

    想看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1078260, encodeId=aa5b10e826028, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:37:48 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063093, encodeId=48ca1063093f2, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:55:10 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063091, encodeId=96a41063091d5, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:47:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056680, encodeId=ad5d1056680e7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Oct 01 00:04:27 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964176, encodeId=66ee9641e695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:42:51 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-10-01 一己怀

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1078260, encodeId=aa5b10e826028, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:37:48 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063093, encodeId=48ca1063093f2, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:55:10 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063091, encodeId=96a41063091d5, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec915630442, createdName=ms1000000819631724, createdTime=Sat Oct 23 06:47:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056680, encodeId=ad5d1056680e7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Oct 01 00:04:27 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964176, encodeId=66ee9641e695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/42581904cacf4a55a95ae91a46516b17/69d7960cce1c4391b1f2ade8a06f882a.jpg, createdBy=63f15392529, createdName=ms7000000855425149, createdTime=Mon May 10 07:42:51 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-05-10 ms7000000855425149

    学习

    0

拓展阅读

2018 KSThR共识声明:多普勒超声检查在甲状腺疾病中的临床应用

韩国甲状腺放射学会(KSThR,Korean Society of Thyroid Radiology) · 2020-08-25